Materials • Major Chemicals
$42.88 ▲ +0.69
(+1.64%)
MKT CAP: $3.93B • VOL: 540.2K
52W L $27 52W H $47
ROARABLE / RQD
B- • 70/100
PIOTROSKI
7 / 9
AVNT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.26B | $3.24B | $3.14B |
| YoY Revenue Growth % | +0.6% | +3.1% | — |
| Gross Profit | $1.02B | $1.06B | — |
| Gross Margin % | 31.2% | 32.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $203.5M | $329.3M | $196.8M |
| Operating Margin % | 6.2% | 10.2% | 6.3% |
| Net Income (GAAP) | $81.9M | $169.5M | $75.7M |
| EBITDA (Normalized) | $288.8M | $426.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $301.6M | $256.8M | $201.6M |
| Capital Expenditures (CapEx) | $106.6M | $121.9M | — |
| Free Cash Flow (FCF) | $195.0M | $134.9M | $201.6M |
| FCF Margin % | 6.0% | 4.2% | 6.4% |
| Return on Invested Capital (ROIC %) | 3.7% | 5.9% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.92B | $2.06B | — |
| Total Stockholders' Equity | $2.37B | $2.31B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AVNT.